Cite

HARVARD Citation

    D'Ambrosio, R. et al. (2020). Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study. Digestive and liver disease. 52 (2), pp. 190-198. [Online]. 
  
Back to record